You are here: Home » PTI Stories » National » News
Business Standard

Shilpa Medicare gets EIR from USFDA for Raichur facility

Press Trust of India  |  New Delhi 

Shilpa today said the US health regulator has issued an establishment inspection report (EIR) for its facility in

"We are in receipt of (establishment inspection report) from the (USFDA) to our both located at Raichur, Karnataka," Shilpa said in a filing.

This inspection was carried out between January 16-19, 2018. The inspection has now been closed by the USFDA, it added.

USFDA gives on closure of inspection of an establishment that is the subject of an FDA or FDA-contracted inspection.

Shares of Shilpa were trading 9.37 per cent higher at Rs 419.45 per scrip on the

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, July 11 2018. 10:50 IST